Turbinia

Turbine is a London and Budapest-based biotechnology company that leverages artificial intelligence to build a platform for digital drug discovery. The company's core technology, the Simulated Cell, is a mechanistic computational model of human cell biology that allows researchers to conduct millions of virtual experiments to identify novel drug targets and predict patient response. By simulating the complex signaling pathways of cancer cells, Turbine aims to overcome the limitations of traditional trial-and-error laboratory methods and improve the success rate of oncology drug development. The company collaborates with major pharmaceutical partners to validate its predictions and advance a pipeline of precision medicine candidates.